Dünya
Ecza Deposu Medical
ABS Hemofili
Ankaferd BloodStopper is effective and safe in controlling external and teeth hemorrhage of patients hemophilic, diabetic and those using anti coagulan (Coumadin) and anti aggregation (Aspirin, Heparin). Genetically transfered, hemophilia is a hemorrhagic diatesis disorder seen among males. Various coagulation factors are needed for the blood to coagulate. Even if one of those factors are missing, the blood’s coagulation mechanism breaks down and unstoppable hemorrhaging occurs.
Depending on the coagulation deficiency (factor VIII or IX) the developing blood disease is called Hemophilia A (factor VIII deficiency) or Hemophilia B (factor IX deficiency).
People are born hemophiliacs and start showing symptoms towards the age of 2. The most minor traumas may cause serious hemorrhaging. Even during a minor dental operation these patients may encounter major problems and unstoppable hemorrhaging can occur.
Therefore these patients must be treated and watched over by a team made up of hematologists, orthopedists, physiotherapists and dentists.
Furthermore a normal person (non-hemophilic) may develop an inhibitor due to an underlying cause (old age, pregnancy, some cancer types, etc) or for no reason at all. This illness is called acquired hemophilia. Unstoppable serious hemorrhaging may occur. Serious complications can occur during surgical interventions ferformed on such patients.0216-4612648-49
Gastric Bleeding
Ankaferd Blood Stopper application for Gastric Bleeding
Subcutaneous bleeding model
Ankaferd Blood Stopper In Vivo Experiment
Venous bleeding model
Ankaferd Blood Stopper In Vivo Experiment
Artery bleeding model
Ankaferd Blood Stopper In Vivo Experiment
ABS affect on blood under microscope
Ankaferd Blood Stopper In Vitro Experiment
Bleeding spleen damage model
Ankaferd Blood Stopper In Vivo Experiment